Galderma Pharma S.A. – Trademark Portfolio

Entity Type: 99

Galderma Pharma S.A. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PLIAGLIS and VECTICAL. The owner is based in Lausanne 30 Grey.

Avenue Gratta-Paille 2

Lausanne 30 Grey 1000 , CH

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Galderma Pharma S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Galderma Pharma S.A. have?

Galderma Pharma S.A. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Galderma Pharma S.A. file in?

Galderma Pharma S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Galderma Pharma S.A.'s most well-known trademarks?

Galderma Pharma S.A.'s registered trademark portfolio includes well-known marks such as PLIAGLIS and VECTICAL. These are among 2 currently registered trademarks in the portfolio.

What is Galderma Pharma S.A.'s trademark registration success rate?

Galderma Pharma S.A. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.